Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer

Joan W. Chen, Ryan P. Russell, Trushna Desai, Mary Fiel-Gan, Varun Bhat, Maria de Fátima Dias Gaui, Luis Claudio Amendola, Zilton Vasconcelos, Adam M. Brufsky, View ORCID ProfileMarcia V. Fournier, Susan H. Tannenbaum
doi: https://doi.org/10.1101/2021.02.10.21251517
Joan W. Chen
1Bioarray Genetics, Inc., Farmington, CT, 06032, USA
2Certis Oncology Solution, San Diego, CA, 92121, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joan1018@yahoo.com stannenbaum@uchc.edu Marcia.fournier@yahoo.com
Ryan P. Russell
1Bioarray Genetics, Inc., Farmington, CT, 06032, USA
3The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trushna Desai
1Bioarray Genetics, Inc., Farmington, CT, 06032, USA
4DotLab, Inc., New Haven, CT, 06513, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Fiel-Gan
5Hartford Hospital, Hartford, CT, 06102, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Varun Bhat
5Hartford Hospital, Hartford, CT, 06102, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria de Fátima Dias Gaui
6Universidade Federal do Rio de Janeiro, Rio de Janeiro, State of Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Claudio Amendola
7Instituto Fernandes Figueira/FIOCRUZ, Rio de Janeiro, RJ, 22250-020, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zilton Vasconcelos
7Instituto Fernandes Figueira/FIOCRUZ, Rio de Janeiro, RJ, 22250-020, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam M. Brufsky
8University of Pittsburgh, Pittsburgh, PA, 15260, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcia V. Fournier
1Bioarray Genetics, Inc., Farmington, CT, 06032, USA
10Dimensions Sciences Inc., Washington DC 20003, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcia V. Fournier
  • For correspondence: joan1018@yahoo.com stannenbaum@uchc.edu Marcia.fournier@yahoo.com
Susan H. Tannenbaum
9UConn Health, Farmington, CT 06030, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joan1018@yahoo.com stannenbaum@uchc.edu Marcia.fournier@yahoo.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is correlated with better outcomes for breast cancer, especially for triple negative breast cancer (TNBC). We developed RNA expression classifiers from a model of breast epithelial cell organization to predict which patients will achieve pCR to NAC, and which will have residual disease (RD). An exclusive collection of retrospective formalin-fixed, paraffin-embedded (FFPE) pretreatment biopsies from 222 multi-institutional breast cancer patients treated with NAC, including 90 TNBC patients, were processed using standard procedures. A novel strategy using machine learning algorithms and statistical cross-validation were used to develop predictive classifiers based on AmpliSeq differential gene expression analysis of patient samples. Two RNA expression classifiers of 18 genes and 15 genes applied sequentially to the total cohort, classified patients into three distinct classes which accurately identified 83.75% of pCR and 86.62% of RD patients in the total population, and 92.10% of pCR and 80.77% of RD patients in the TNBC subset. This new approach identified a subset of TNBC patients predicted to have RD showing significantly higher levels of Ki-67 expression and having significantly poorer survival rates than the other TNBC patients. Stratification of patients may allow identification of TNBC patients with the worst prognosis prior to NAC, allowing for personalized treatments with the potential to improve patient outcomes.

Statement of Significance Stratification of TNBC patients by prognosis prior to NAC, may allow for more personalized treatment approaches with the potential to improve patient outcomes and reduce toxicity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded with private funds by Bioarray Genetics Inc.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All samples were obtained under IRB review and were waived from consent. UConn Health, Hartford Hospital and FIOCRUZ institute sample collection was approved under UConn IRB #17-013-6.1.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclosure of conflict of interest: J.W.C is an employee and shareholder of Certis Oncology Solution. Other authors declare no potential conflicts of interest.

Data Availability

The data will become available at GEO on March 1, 2021

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer
Joan W. Chen, Ryan P. Russell, Trushna Desai, Mary Fiel-Gan, Varun Bhat, Maria de Fátima Dias Gaui, Luis Claudio Amendola, Zilton Vasconcelos, Adam M. Brufsky, Marcia V. Fournier, Susan H. Tannenbaum
medRxiv 2021.02.10.21251517; doi: https://doi.org/10.1101/2021.02.10.21251517
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer
Joan W. Chen, Ryan P. Russell, Trushna Desai, Mary Fiel-Gan, Varun Bhat, Maria de Fátima Dias Gaui, Luis Claudio Amendola, Zilton Vasconcelos, Adam M. Brufsky, Marcia V. Fournier, Susan H. Tannenbaum
medRxiv 2021.02.10.21251517; doi: https://doi.org/10.1101/2021.02.10.21251517

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5867)
  • Intensive Care and Critical Care Medicine (361)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (231)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2011)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)